Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-0921-2025 — DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

U.S. FDA — Device Enforcement · United States · 2024-10-07 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-0921-2025
Date of alert
2024-10-07
Country / jurisdiction
United States
Risk level
Class II
Risk type
recall
Brand
DRG International, Inc.
Product category
device
Product type
Devices
Barcode (EAN/GTIN)
04048474053616
Reported risk: The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.